SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Marker Therapeutics Q1 EPS $(0.140) Misses $(0.110) Estimate

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.140) per share which missed the analyst consensus estimate of $(0.110) by 27.27 percent.

Benzinga · 05/11/2020 20:11

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.140) per share which missed the analyst consensus estimate of $(0.110) by 27.27 percent.